These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4530133)

  • 1. [Cytokinetic effect of cytosine arabinoside in clinical tests].
    Barlogie B; Büchner T; Asseburg U; Kamanabroo D
    Med Welt; 1974 Sep; 25(39):1532-4. PubMed ID: 4530133
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of cytosine arabinoside on cell kinetics in adult acute leukemia and its correlation to the therapeutic response].
    Furusawa S; Adachi Y; Nomura T; Komiya M
    Rinsho Ketsueki; 1972 Dec; 13(6):943-50. PubMed ID: 4675065
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of cytosine arabinoside and daunomycin on cell kinetics in childhood acute myeloblastic leukemia].
    Tsukimoto I; Toyosaka H; Tashiro Y; Nagao T
    Rinsho Ketsueki; 1973 Jul; 14(7):762-8. PubMed ID: 4517365
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of recent studies of cellular proliferation in acute leukemia.
    Clarkson BD
    Natl Cancer Inst Monogr; 1969 May; 30():81-120. PubMed ID: 5260445
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential advances in the clinical use of arabinosyl cytosine.
    Ho DH
    Cancer Treat Rep; 1977 Jul; 61(4):717-22. PubMed ID: 267509
    [No Abstract]   [Full Text] [Related]  

  • 8. Correlation of cytosine arabinoside-induced increment in growth fraction of leukemic blast cells with clinical response.
    Vogler WR; Cooper LE; Groth DP
    Cancer; 1974 Mar; 33(3):603-10. PubMed ID: 4544535
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Low-dose cytosine arabinoside treatment in acute myeloid leukemia].
    Jensen MK; Ahlbom G; Leegaard OF
    Ugeskr Laeger; 1984 Aug; 146(35):2613-5. PubMed ID: 6595867
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary results of the treatment of various forms of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
    Brodzki LM; Pawelski S; Gepner-Woźniewska M
    Pol Tyg Lek; 1986 Oct; 41(43):1376-9. PubMed ID: 3469629
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of acute myeloid leukemia by the combination therapy of 6-mercaptopurine and cytosine arabinoside--evaluation of twenty-two cases].
    Amano I; Higo O; Oshima T; Horiuchi A; Morita K
    Saishin Igaku; 1970 Sep; 25(9):1928-37. PubMed ID: 5272335
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 14. Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside.
    Ernst P; Faille A; Killmann SA
    Scand J Haematol; 1973; 10(3):209-18. PubMed ID: 4520466
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with daunomycin and cytosine arabinoside in the therapy of acute myeloid leukemias].
    Kreiter H; Begemann H; Rastetter J
    Med Klin; 1968 Dec; 63(51):2058-66. PubMed ID: 5255517
    [No Abstract]   [Full Text] [Related]  

  • 16. Two years' experience in the treatment of acute myeloid leukaemia using a three-drug regimen: daunorubicin, cytosine arabinoside and 6-thioguanine.
    McCann SR; Lawlor E; Kinsella IA; Temperley IJ
    Ir Med J; 1982 Nov; 75(11):415-7. PubMed ID: 6959984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reduced dosage of cytosine arabinoside in the treatment of acute myelocytic leukemia. Apropos of 3 cases].
    Andrey C; Beris P; Plancherel C; de Loes S; Maurice P; Chapuis B
    Schweiz Med Wochenschr; 1983 Jul; 113(27-28):980-4. PubMed ID: 6577584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia.
    Xiao Z; Xue H; Li R; Zhang L; Yu M; Hao Y
    Am J Hematol; 2008 Mar; 83(3):203-5. PubMed ID: 17874451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
    Burke PJ; Karp JE; Vaughan WP
    J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
    Buchanan JG
    N Z Med J; 1971 Sep; 74(471):153-9. PubMed ID: 5289827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.